As of 2026-10-30, the EV/EBITDA ratio of Blueprint Medicines Corp (BPMC) is -54.80. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BPMC's latest enterprise value is 8,637.68 mil USD. BPMC's TTM EBITDA according to its financial statements is -157.63 mil USD. Dividing these 2 quantities gives us the above BPMC EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.6x - 15.2x | 15.0x |
| Forward P/E multiples | 14.3x - 22.2x | 17.6x |
| Fair Price | (39.06) - (41.11) | (43.77) |
| Upside | -130.2% - -131.8% | -133.8% |
| Date | EV/EBITDA |